89R HB 2412
by Rep. Bucy, same lead author · Died in committee · same text
Introduced textLast action, Mar 17, 2025: Referred to Insurance
Relating to health benefit plan coverage for certain obesity medications.
Caption, 89R bill history
HB 537
Filed
Initial review · graded Nov 9, 2026 · How we grade
relating to health benefit plan coverage for certain obesity medications.
Caption from analyzed text · version I.
Private plans, state employee and teacher plans, and Medicaid must pay. Starts January 1, 2028.
The bill requires health plans that cover prescription drugs to also cover GLP-1 receptor agonist drugs used to treat obesity. It reaches private insurers and HMOs, the state employee and teacher health plans, and the state Medicaid program, including Medicaid managed care. Starting with plans issued or renewed on or after January 1, 2028, these plans must pay for these weight-loss drugs, and state agencies may hold off on any part that needs federal approval until they get it.
Labels: BACK FROM THE DEAD. Same text as a bill filed before that died: 89R HB 2412 (Died in committee). Filed in 2 sessions, counting this one. Checked against 88R and 89R only.TRY NO. 2. Filed in 2 sessions: 89R and 90R. Checked against 88R and 89R only.
90R-HB537 · 2026-11-09
relating to health benefit plan coverage for certain obesity medications.
Private plans, state employee and teacher plans, and Medicaid must pay. Starts January 1, 2028.
The bill requires health plans that cover prescription drugs to also cover GLP-1 receptor agonist drugs used to treat obesity. It reaches private insurers and HMOs, the state employee and teacher health plans, and the state Medicaid program, including Medicaid managed care. Starting with plans issued or renewed on or after January 1, 2028, these plans must pay for these weight-loss drugs, and state agencies may hold off on any part that needs federal approval until they get it.
[ ] NONE FOUND
No fiscal note in the loaded record.
THE TEXT
…“must provide coverage for a prescription drug that is a glucagon-like peptide-1 receptor agonist to treat obesity”
Bill text, introduced version (I)
The bill makes health plans cover one class of prescription obesity drugs, a coverage mandate for a specific drug type sold through the prescription channel.
THE TEXT
“the state Medicaid program, including the Medicaid managed care program operated under Chapter 540, Government Code”
Bill text, introduced version (I)
The bill adds GLP-1 obesity drug coverage as a new benefit in Medicaid and in the state-funded employee and teacher health plans.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
Not tied to this bill.
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Oct 28, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
$56,000.00
Also funds 5 other sitting lawmakers.
Derived recipient stock · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.
TEC account match.
Derived itemized flow · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986907, 101059773, 101069326, 101072293.
$17,000.00
Also funds 121 other sitting lawmakers.
Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Dec 9, 2024 to Sep 29, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986907, 101032801, 101059773, 101072293.
Missing data does not establish zero giving. Display amounts are rounded.
$56,000.00
Also funds 5 other sitting lawmakers.
Derived recipient stock · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.
TEC account match.
Derived itemized flow · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986907, 101059773, 101069326, 101072293.
$17,000.00
Also funds 121 other sitting lawmakers.
Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Dec 9, 2024 to Sep 29, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986907, 101032801, 101059773, 101072293.
No floor vote loaded for this bill.
No fiscal note in the loaded record.
Analysis of text version I by a super-expensive superintelligence, Nov 9, 2026, against the published rubric.
Filed 2 times: 89R and now. Checked against 88R and 89R only.
by Rep. Bucy, same lead author · Died in committee · same text
Introduced textLast action, Mar 17, 2025: Referred to Insurance
Relating to health benefit plan coverage for certain obesity medications.
Caption, 89R bill history
Texas House · Filed Nov 9, 2026
11/09/2026 H Filed
Texas Legislature Online · Introduced
Data snapshot Nov 10, 2026 at 2:34 AM CST. Grades, charges, quotes and corrections follow the published record.
Health--Other Diseases & Medical Conditions
Human Services--Medical Assistance
Insurance--Health & Accident
Retirement Systems--State Employees
Retirement Systems--Teachers
The text as introduced · 393 words
90R690 SCF-D By: Bucy H.B. No. 537 A BILL TO BE ENTITLED AN ACT relating to health benefit plan coverage for certain obesity medications. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Chapter 1369, Insurance Code, is amended by adding Subchapter R to read as follows: SUBCHAPTER R. COVERAGE FOR CERTAIN OBESITY MEDICATIONS Sec. 1369.781. APPLICABILITY OF SUBCHAPTER. (a) This subchapter applies only to a health benefit plan that provides benefits for medical or surgical expenses incurred as a result of a health condition, accident, or sickness, including an individual, group, blanket, or franchise insurance policy or insurance agreement, a group hospital service contract, or an individual or group evidence of coverage or similar coverage document that is issued by: (1) an insurance company; (2) a group hospital service corporation operating under Chapter 842; (3) a health maintenance organization operating under Chapter 843; (4) an approved nonprofit health corporation that holds a certificate of authority under Chapter 844; (5) a multiple employer welfare arrangement that holds a certificate of authority under Chapter 846; (6) a stipulated premium company operating under Chapter 884; (7) a fraternal benefit society operating under Chapter 885; (8) a Lloyd's plan operating under Chapter 941; or (9) an exchange operating under Chapter 942. (b) Notwithstanding any other law, this subchapter applies to: (1) a basic coverage plan under Chapter 1551; (2) a basic plan under Chapter 1575; (3) a primary care coverage plan under Chapter 1579; and (4) the state Medicaid program, including the Medicaid managed care program operated under Chapter 540, Government Code. Sec. 1369.782. COVERAGE REQUIRED FOR CERTAIN OBESITY MEDICATIONS. A health benefit plan that provides prescription drug benefits must provide coverage for a prescription drug that is a glucagon-like peptide-1 receptor agonist to treat obesity. SECTION 2. If before implementing any provision of this Act a state agency determines that a waiver or authorization from a federal agency is necessary for implementation of that provision, the agency affected by the provision shall request the waiver or authorization and may delay implementing that provision until the waiver or authorization is granted. SECTION 3. Subchapter R, Chapter 1369, Insurance Code, as added by this Act, applies only to a health benefit plan delivered, issued for delivery, or renewed on or after January 1, 2028. SECTION 4. This Act takes effect September 1, 2027.